{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T13:33:41Z","timestamp":1787664821818,"version":"build-2736575974"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T00:00:00Z","timestamp":1752537600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T00:00:00Z","timestamp":1752537600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100004735","name":"Natural Science Foundation of Hunan Province","doi-asserted-by":"publisher","award":["2025JJ80829"],"award-info":[{"award-number":["2025JJ80829"]}],"id":[{"id":"10.13039\/501100004735","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Nucl Med Mol Imaging"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s00259-025-07433-6","type":"journal-article","created":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T04:44:23Z","timestamp":1752554663000},"page":"398-407","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["[18F]AlF-NOTA-FAPI-04 PET\/CT improves detection of subcentimeter recurrent lesions in differentiated thyroid cancer"],"prefix":"10.1007","volume":"53","author":[{"given":"Kai","family":"Zheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wanjing","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanyin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengzhi","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aimin","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiashun","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haifeng","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3028-1045","authenticated-orcid":false,"given":"Xiaowei","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9339-4090","authenticated-orcid":false,"given":"Hui","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,15]]},"reference":[{"key":"7433_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s40336-024-00672-x","volume":"13","author":"M Wang","year":"2025","unstructured":"Wang M, Liu H, Zhang J, Wu B, Zhang C. Progress in the application of radiolabeled FAPI in advanced differentiated thyroid cancer. Clin Translational Imaging. 2025;13:1\u20138. https:\/\/doi.org\/10.1007\/s40336-024-00672-x.","journal-title":"Clin Translational Imaging"},{"key":"7433_CR2","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global Cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71:209\u201349. https:\/\/doi.org\/10.3322\/caac.21660.","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"7433_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1089\/thy.2015.0020","volume":"26","author":"BR Haugen","year":"2016","unstructured":"Haugen BR, Alexander EK, Bible KC, Doherty GM, Mandel SJ, Nikiforov YE, Wartofsky L, et al. 2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer. Thyroid. 2016Jan;26(1):1\u2013133. https:\/\/doi.org\/10.1089\/thy.2015.0020.","journal-title":"Thyroid."},{"key":"7433_CR4","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1001\/jamasurg.2018.2659","volume":"153","author":"ML Hung","year":"2018","unstructured":"Hung ML, Wu JX, Li N, Livhits MJ, Yeh MW. Association of radioactive iodine administration after reoperation with outcomes among patients with recurrent or persistent papillary thyroid Cancer. JAMA Surg. 2018;153:1098\u2013104. https:\/\/doi.org\/10.1001\/jamasurg.2018.2659.","journal-title":"JAMA Surg"},{"key":"7433_CR5","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1002\/prca.201300095","volume":"8","author":"EJ Hamson","year":"2014","unstructured":"Hamson EJ, Keane FM, Tholen S, Schilling O, Gorrell MD. Understanding fibroblast activation protein (FAP): substrates, activities, expression and targeting for cancer therapy. Proteom Clin Appl. 2014;8:454\u201363. https:\/\/doi.org\/10.1002\/prca.201300095.","journal-title":"Proteom Clin Appl"},{"key":"7433_CR6","doi-asserted-by":"publisher","first-page":"8197","DOI":"10.1007\/s13277-015-4684-4","volume":"37","author":"W-Y Sun","year":"2016","unstructured":"Sun W-Y, Jung W-H, Koo JS. Expression of cancer-associated fibroblast-related proteins in thyroid papillary carcinoma. Tumour Biol. 2016;37:8197\u2013207. https:\/\/doi.org\/10.1007\/s13277-015-4684-4.","journal-title":"Tumour Biol"},{"key":"7433_CR7","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.2147\/OTT.S294725","volume":"14","author":"S Wen","year":"2021","unstructured":"Wen S, Qu N, Ma B, Wang X, Luo Y, Xu W, et al. Cancer-Associated fibroblasts positively correlate with dedifferentiation and aggressiveness of thyroid Cancer. Onco Targets Ther. 2021;14:1205\u201317. https:\/\/doi.org\/10.2147\/OTT.S294725.","journal-title":"Onco Targets Ther"},{"key":"7433_CR8","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1148\/radiol.212430","volume":"304","author":"H Fu","year":"2022","unstructured":"Fu H, Wu J, Huang J, Sun L, Wu H, Guo W, et al. (68)Ga fibroblast activation protein inhibitor PET\/CT in the detection of metastatic thyroid cancer: comparison with (18)F-FDG PET\/CT. Radiology. 2022;304:397\u2013405. https:\/\/doi.org\/10.1148\/radiol.212430.","journal-title":"Radiology"},{"key":"7433_CR9","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1007\/s00259-022-06067-2","volume":"50","author":"X Mu","year":"2023","unstructured":"Mu X, Huang X, Jiang Z, Li M, Jia L, Lv Z, et al. [18F]FAPI-42 PET\/CT in differentiated thyroid cancer: diagnostic performance, uptake values, and comparison with 2-[18F]FDG PET\/CT. Eur J Nucl Med Mol Imaging. 2023;50:1205\u201315. https:\/\/doi.org\/10.1007\/s00259-022-06067-2.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"7433_CR10","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1007\/s12149-022-01742-8","volume":"36","author":"Y Chen","year":"2022","unstructured":"Chen Y, Zheng S, Zhang J, Yao S, Miao W. 68Ga-DOTA-FAPI-04 PET\/CT imaging in radioiodine-refractory differentiated thyroid cancer (RR-DTC) patients. Ann Nucl Med. 2022;36:610\u201322. https:\/\/doi.org\/10.1007\/s12149-022-01742-8.","journal-title":"Ann Nucl Med"},{"key":"7433_CR11","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1007\/s11307-015-0866-0","volume":"17","author":"M Dietlein","year":"2015","unstructured":"Dietlein M, Kobe C, Kuhnert G, Stockter S, Fischer T, Schom\u00e4cker K, et al. Comparison of [(18)F]DCFPyL and [ (68)Ga]Ga-PSMA-HBED-CC for PSMA-PET imaging in patients with relapsed prostate Cancer. Mol Imaging Biology. 2015;17:575\u201384. https:\/\/doi.org\/10.1007\/s11307-015-0866-0.","journal-title":"Mol Imaging Biology"},{"key":"7433_CR12","doi-asserted-by":"publisher","first-page":"2761","DOI":"10.1007\/s00259-022-05758-0","volume":"49","author":"Y Wei","year":"2022","unstructured":"Wei Y, Zheng J, Ma L, Liu X, Xu S, Wang S, et al. [18F]AlF-NOTA-FAPI-04: FAP-targeting specificity, biodistribution, and PET\/CT imaging of various cancers. Eur J Nucl Med Mol Imaging. 2022;49:2761\u201373. https:\/\/doi.org\/10.1007\/s00259-022-05758-0.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"7433_CR13","doi-asserted-by":"publisher","first-page":"1587","DOI":"10.1186\/s12885-024-13211-8","volume":"24","author":"H Liu","year":"2024","unstructured":"Liu H, Zhang S, Liu X, Wang Q, Zhang H, Cui W. Thyroid cancer survival and prognostic factors in yantai, China (2012\u20132022): a population-based study. BMC Cancer. 2024;24:1587. https:\/\/doi.org\/10.1186\/s12885-024-13211-8.","journal-title":"BMC Cancer"},{"key":"7433_CR14","doi-asserted-by":"publisher","first-page":"1427649","DOI":"10.3389\/fonc.2024.1427649","volume":"14","author":"J Yang","year":"2024","unstructured":"Yang J, Wu Y, Zhang Y, Peng X, Jiang C, Zhou W, et al. Comparative assessment of the diagnostic efficacy of [18F]AlF-NOTA-FAPI-04 and [18F]FDG PET\/CT imaging for detecting postoperative recurrence in gastric cancer patients: a pilot study. Front Oncol. 2024;14:1427649. https:\/\/doi.org\/10.3389\/fonc.2024.1427649.","journal-title":"Front Oncol"},{"key":"7433_CR15","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.2967\/jnumed.118.210443","volume":"59","author":"T Lindner","year":"2018","unstructured":"Lindner T, Loktev A, Altmann A, Giesel F, Kratochwil C, Debus J, et al. Development of Quinoline-Based theranostic ligands for the targeting of fibroblast activation protein. J Nuclear Medicine: Official Publication Soc Nuclear Med. 2018;59:1415\u201322. https:\/\/doi.org\/10.2967\/jnumed.118.210443.","journal-title":"J Nuclear Medicine: Official Publication Soc Nuclear Med"},{"key":"7433_CR16","doi-asserted-by":"publisher","first-page":"801","DOI":"10.2967\/jnumed.119.227967","volume":"60","author":"C Kratochwil","year":"2019","unstructured":"Kratochwil C, Flechsig P, Lindner T, Abderrahim L, Altmann A, Mier W, et al. 68Ga-FAPI PET\/CT: tracer uptake in 28 different kinds of Cancer. J Nuclear Medicine: Official Publication Soc Nuclear Med. 2019;60:801\u20135. https:\/\/doi.org\/10.2967\/jnumed.119.227967.","journal-title":"J Nuclear Medicine: Official Publication Soc Nuclear Med"},{"key":"7433_CR17","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.1089\/thy.2012.0043","volume":"22","author":"GW Randolph","year":"2012","unstructured":"Randolph GW, Duh Q-Y, Heller KS, LiVolsi VA, Mandel SJ, Steward DL, et al. The prognostic significance of nodal metastases from papillary thyroid carcinoma can be stratified based on the size and number of metastatic lymph nodes, as well as the presence of extranodal extension. Thyroid: Official J Am Thyroid Association. 2012;22:1144\u201352. https:\/\/doi.org\/10.1089\/thy.2012.0043.","journal-title":"Thyroid: Official J Am Thyroid Association"},{"key":"7433_CR18","doi-asserted-by":"publisher","first-page":"386","DOI":"10.2967\/jnumed.118.215913","volume":"60","author":"FL Giesel","year":"2019","unstructured":"Giesel FL, Kratochwil C, Lindner T, Marschalek MM, Loktev A, Lehnert W, et al. 68Ga-FAPI PET\/CT: biodistribution and preliminary dosimetry estimate of 2 DOTA-Containing FAP-Targeting agents in patients with various cancers. J Nuclear Medicine: Official Publication Soc Nuclear Med. 2019;60:386\u201392. https:\/\/doi.org\/10.2967\/jnumed.118.215913.","journal-title":"J Nuclear Medicine: Official Publication Soc Nuclear Med"},{"key":"7433_CR19","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.2967\/jnumed.118.210435","volume":"59","author":"A Loktev","year":"2018","unstructured":"Loktev A, Lindner T, Mier W, Debus J, Altmann A, J\u00e4ger D, et al. A Tumor-Imaging method targeting Cancer-Associated fibroblasts. J Nuclear Medicine: Official Publication Soc Nuclear Med. 2018;59:1423\u20139. https:\/\/doi.org\/10.2967\/jnumed.118.210435.","journal-title":"J Nuclear Medicine: Official Publication Soc Nuclear Med"},{"key":"7433_CR20","doi-asserted-by":"publisher","first-page":"779","DOI":"10.2967\/jnumed.120.253062","volume":"62","author":"M R\u00f6hrich","year":"2021","unstructured":"R\u00f6hrich M, Naumann P, Giesel FL, Choyke PL, Staudinger F, Wefers A, et al. Impact of 68Ga-FAPI PET\/CT imaging on the therapeutic management of primary and recurrent pancreatic ductal adenocarcinomas. J Nucl Med. 2021;62:779. https:\/\/doi.org\/10.2967\/jnumed.120.253062.","journal-title":"J Nucl Med"},{"key":"7433_CR21","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1210\/jc.2005-1534","volume":"91","author":"RJ Robbins","year":"2006","unstructured":"Robbins RJ, Wan Q, Grewal RK, Reibke R, Gonen M, Strauss HW, et al. Real-time prognosis for metastatic thyroid carcinoma based on 2-[18F]fluoro-2-deoxy-D-glucose-positron emission tomography scanning. J Clin Endocrinol Metab. 2006;91:498\u2013505.","journal-title":"J Clin Endocrinol Metab"},{"key":"7433_CR22","doi-asserted-by":"publisher","first-page":"2783","DOI":"10.1016\/S0140-6736(16)30172-6","volume":"388","author":"ME Cabanillas","year":"2016","unstructured":"Cabanillas ME, McFadden DG, Durante C. Thyroid cancer. Lancet. 2016;388:2783\u201395. https:\/\/doi.org\/10.1016\/S0140-6736(16)30172-6.","journal-title":"Lancet"},{"key":"7433_CR23","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1007\/s00259-020-04940-6","volume":"48","author":"H Chen","year":"2021","unstructured":"Chen H, Zhao L, Ruan D, Pang Y, Hao B, Dai Y, et al. Usefulness of [68Ga]Ga-DOTA-FAPI-04 PET\/CT in patients presenting with inconclusive [18F]FDG PET\/CT findings. Eur J Nucl Med Mol Imaging. 2021;48:73\u201386. https:\/\/doi.org\/10.1007\/s00259-020-04940-6.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"7433_CR24","doi-asserted-by":"publisher","first-page":"2892","DOI":"10.1210\/jc.2005-2838","volume":"91","author":"C Durante","year":"2006","unstructured":"Durante C, Haddy N, Baudin E, Leboulleux S, Hartl D, Travagli JP, et al. Long-term outcome of 444 patients with distant metastases from papillary and follicular thyroid carcinoma: benefits and limits of radioiodine therapy. J Clin Endocrinol Metab. 2006;91:2892\u20139.","journal-title":"J Clin Endocrinol Metab"},{"key":"7433_CR25","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1530\/eje.1.02014","volume":"153","author":"F Pacini","year":"2005","unstructured":"Pacini F, Schlumberger M, Harmer C, Berg GG, Cohen O, Duntas L, et al. Post-surgical use of radioiodine (131I) in patients with papillary and follicular thyroid cancer and the issue of remnant ablation: a consensus report. Eur J Endocrinol. 2005;153:651\u20139.","journal-title":"Eur J Endocrinol"},{"key":"7433_CR26","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.2967\/jnumed.117.192559","volume":"59","author":"RM Tuttle","year":"2018","unstructured":"Tuttle RM. Controversial issues in thyroid Cancer management. J Nuclear Medicine: Official Publication Soc Nuclear Med. 2018;59:1187\u201394. https:\/\/doi.org\/10.2967\/jnumed.117.192559.","journal-title":"J Nuclear Medicine: Official Publication Soc Nuclear Med"},{"key":"7433_CR27","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1007\/s00259-023-06404-z","volume":"51","author":"S Ballal","year":"2023","unstructured":"Ballal S, Yadav MP, Roesch F, Satapathy S, Moon ES, Martin M, et al. Head-to-head comparison of [68Ga]Ga-DOTA.SA.FAPi with [18F]F-FDG PET\/CT in radioiodine-resistant follicular-cell derived thyroid cancers. Eur J Nucl Med Mol Imaging. 2023;51:233\u201344. https:\/\/doi.org\/10.1007\/s00259-023-06404-z.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"7433_CR28","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1038\/s44303-024-00053-z","volume":"2","author":"Y Mori","year":"2024","unstructured":"Mori Y, Novruzov E, Schmitt D, Cardinale J, Watabe T, Choyke PL, et al. Clinical applications of fibroblast activation protein inhibitor positron emission tomography (FAPI-PET). Npj Imaging. 2024;2:48. https:\/\/doi.org\/10.1038\/s44303-024-00053-z.","journal-title":"Npj Imaging"},{"key":"7433_CR29","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1038\/s41392-024-01853-w","volume":"9","author":"L Zhao","year":"2024","unstructured":"Zhao L, Pang Y, Zhou Y, Chen J, Fu H, Guo W, et al. Antitumor efficacy and potential mechanism of FAP-targeted radioligand therapy combined with immune checkpoint Blockade. Signal Transduct Target Ther. 2024;9:142. https:\/\/doi.org\/10.1038\/s41392-024-01853-w.","journal-title":"Signal Transduct Target Ther"},{"key":"7433_CR30","doi-asserted-by":"publisher","first-page":"4740","DOI":"10.1158\/1078-0432.CCR-23-1983","volume":"29","author":"H Fu","year":"2023","unstructured":"Fu H, Huang J, Zhao T, Wang H, Chen Y, Xu W, et al. Fibroblast activation Protein-Targeted radioligand therapy with 177Lu-EB-FAPI for metastatic Radioiodine-Refractory thyroid cancer: First-in-Human, Dose-Escalation study. Clin Cancer Res. 2023;29:4740\u201350. https:\/\/doi.org\/10.1158\/1078-0432.CCR-23-1983.","journal-title":"Clin Cancer Res"},{"key":"7433_CR31","first-page":"241976","volume":"65","author":"H Fu","year":"2024","unstructured":"Fu H, Huang J, Guo W, Wu H, Chen H. Initial clinical experience with 177Lu-EB-FAPI radioligand therapy in patients with End-Stage metastatic cancers. J Nucl Med. 2024;65:241976.","journal-title":"J Nucl Med"},{"key":"7433_CR32","doi-asserted-by":"publisher","DOI":"10.1007\/s11604-024-01714-0","author":"X Tian","year":"2024","unstructured":"Tian X, Wang Y, Zhang Y, Teng Y, Cui Z, Liu J. Evaluating the diagnostic value of 18F-FAPI-04 PET\/CT in various malignant tumors: a head-to-head comparison with 18F-FDG PET\/CT. Japanese J Radiol. 2024. https:\/\/doi.org\/10.1007\/s11604-024-01714-0.","journal-title":"Japanese J Radiol"},{"key":"7433_CR33","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1089\/thy.2023.0328","volume":"34","author":"K Bach","year":"2024","unstructured":"Bach K, Ansari P, Ansari H, Mott NM, Elfenbein DM, Underwood H, et al. Health-Related quality of life in patients with Low-Risk differentiated thyroid cancer: A systematic review examining the extent of thyroidectomy. Thyroid: Official J Am Thyroid Association. 2024;34:14\u201325. https:\/\/doi.org\/10.1089\/thy.2023.0328.","journal-title":"Thyroid: Official J Am Thyroid Association"}],"container-title":["European Journal of Nuclear Medicine and Molecular Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-025-07433-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00259-025-07433-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-025-07433-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,27]],"date-time":"2025-11-27T05:05:53Z","timestamp":1764219953000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00259-025-07433-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,15]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["7433"],"URL":"https:\/\/doi.org\/10.1007\/s00259-025-07433-6","relation":{},"ISSN":["1619-7070","1619-7089"],"issn-type":[{"value":"1619-7070","type":"print"},{"value":"1619-7089","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,15]]},"assertion":[{"value":"18 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Ethics Committee of Hunan Cancer Hospital (2021 New Medical Technology Expedited Review [No. 02]).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"The authors affirm that human research participants provided informed consent for publication of the images in Figs.\u00a01 and 2 3 and 4.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publish"}},{"value":"The authors have no relevant financial or non-financial interests to disclose.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}